BeStock  
Markets › Compare › RDY vs NBIX

RDY vs NBIX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
RDY · Dr. Reddy's Laboratories$14.89 ▲ 0.40%
NBIX · Neurocrine Biosciences$150.57 ▼ 3.84%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8094107121134Nov 24, '25May 26, '26Nov 20, '26
  • RDY +9.8%
  • NBIX +6.6%

Head to head

MetricRDYNBIX
Price$14.89$150.57
Change today▲ 0.40%▼ 3.84%
Market cap$12.41B$15.24B
Return, 3 months+21.8%-1.6%
Return, year to date+6.8%+6.2%
Return, 1 year+7.8%+6.2%
P/E (TTM)41.422.3
P/B3.03.9
P/E percentile vs own 5y99th8th
Dividend yield0.56%–
Revenue growth (YoY, latest qtr)-1.5%+41.2%
Net profit growth (YoY)-36.0%-1.4%
Gross margin49.5%97.7%
Operating margin9.5%24.6%
Net margin8.5%19.0%
Return on equity7.5%20.4%
Analyst target vs. price-3.3%+37.7%
Analyst buy share67%84%
RSI (14)6843
30-day volatility21.8%50.0%
Max drawdown, 1 year-26.0%-27.2%
Trend readStrong uptrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NBIX is the largest of the group by market value.
  • RDY has returned the most over the past year.
  • NBIX carries the lowest trailing P/E.
  • NBIX is growing revenue fastest.
  • NBIX keeps the most profit per dollar of sales.
  • RDY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top